Research Archives
Blood mutations increase risk for acute kidney injury: study
Mar. 7, 2024—A U.S.-Canadian research collaboration led by Vanderbilt University Medical Center has identified common, age-associated changes in the blood as a risk factor for acute kidney injury, which occurs in more than 1 in 5 hospitalized adults worldwide.
Dame Frances Ashcroft to deliver March 21 Vanderbilt Prize Lecture
Mar. 4, 2024—Professor Dame Frances Ashcroft, recipient of the 2023 Vanderbilt Prize in Biomedical Science, will deliver her Vanderbilt Prize Discovery Lecture at 4 p.m. Thursday, March 21, in 208 Light Hall.
Large, diverse genetic study of glaucoma implicates vascular and cancer-related genes
Feb. 21, 2024—An international genetic study using multiancestry biobanks has identified novel genetic locations associated with primary open-angle glaucoma, the most common type of glaucoma and the leading cause of irreversible blindness globally.
VUMC part of major step to achieving precision medicine
Feb. 19, 2024—An analysis of genomic data from nearly 250,000 participants in the National Institutes of Health’s All of Us Research Program has identified more than 275 million previously unreported genetic variations, nearly 4 million of which have potential health consequences.
VISTA grant to fund hospital-based research training in heart, lung, blood, sleep disorders
Feb. 12, 2024—Vanderbilt University Medical Center has received a federal grant to establish a first-of-its-kind training program in patient-oriented and health systems research focused on acute heart, lung, blood and sleep disorders in the hospital setting.
Vanderbilt nanodrug may be a paradigm shift for cancer
Feb. 7, 2024—A multidisciplinary research team at Vanderbilt University and Vanderbilt University Medical Center has discovered a new way to kill a tumor by disrupting its acidic “microenvironment” without harming normal tissue.
VUMC study finds molecular switch key to repair of kidney damage
Feb. 7, 2024—Researchers at Vanderbilt University Medical Center have identified Rac1, a molecular switch that regulates the actin cytoskeleton of epithelial cells in the collecting ducts, as a driver of post-obstructive kidney repair.
A biomarker for early Type 2 diabetes
Feb. 1, 2024—Genetic analyses suggest that branched chain amino acids may be a sensitive biomarker of early or subclinical Type 2 diabetes and could be used to identify risk and implement preventive measures.
Fatty acids rewire energy supply chain in stomach cancer development
Jan. 31, 2024—A study by Vanderbilt researchers has revealed how metabolic changes spurred by fatty acids contribute to the transformation of cells into abnormal versions of themselves that are the precursors to stomach cancer.
3D brain mapping opens a window to the aging brain
Jan. 30, 2024—By mapping brain activity in three dimensions, researchers at Vanderbilt University Medical Center have achieved a more detailed picture of how the brain changes with age.
Expanded space boosts cutting-edge research in infectious diseases and immunology
Jan. 29, 2024—The Vanderbilt Institute for Infection, Immunology and Inflammation recently debuted state-of-the-art new facilities in Medical Center.
Harvard immunologist Springer next up in Discovery Lecture Series
Jan. 29, 2024—Harvard's Timothy Springer, PhD, a world leader in structural biology and immunology, will deliver the next Discovery Lecture at Vanderbilt on Thursday, Feb. 8.